Author

Alexander G. Gabibov

National Research University Higher School of EconomicsORCID 0000-0001-8665-3288Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

А. С. ЧерновiD· 2 shared Alexey A. BeloguroviD· 1 shared Alexey V. StepanoviD· 1 shared Anna A. KudriaevaiD· 1 shared Daria S. OsipovaiD· 1 shared Ding ZhangiD· 1 shared Dmitry PershiniD· 1 shared Dmitry V. VolkoviD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

А. С. ЧерновORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologyMolecular Therapy OncologyPeer-reviewedJun 27, 2024

Targeting CD45 by gene-edited CAR-T cells for leukemia eradication and hematopoietic stem cell transplantation preconditioning

Valeria M. Stepanova, Dmitry V. Volkov, Daria S. Osipova…·Alexey V. Stepanov

This paper demonstrates the preclinical efficacy of CD45-targeting CAR T and NK cells for leukemia treatment and HSCT preconditioning, showing reduced fratricide through gene editing.

9 citations

humanexperimental assay

𝕏 PostBluesky

PathologyFrontiers in PharmacologyPeer-reviewedFeb 20, 2024

CCR5/CXCR3 antagonist TAK-779 prevents diffuse alveolar damage of the lung in murine model of the SARS-CoV-2-related acute respiratory distress syndrome

А. С. Чернов, Maksim V. Rodionov, Vitaly A. Kazakov…·Alexey A. Belogurov

This paper shows that TAK-779, a CCR5/CXCR3 antagonist, prevents diffuse alveolar damage in a murine model of SARS-CoV-2-induced ARDS by reducing mononuclear infiltration and cytokine levels.

13 citations

mouseexperimental assay

𝕏 PostBluesky